Cargando…
Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease
The use of mutation analysis of homologous recombination repair (HRR) genes to estimate PARP‐inhibition response may miss a larger proportion of responding patients. Here, we provide preclinical models for castration‐resistant prostate cancer (CRPC) that can be used to functionally predict HRR defec...
Autores principales: | Elsesy, Mohamed E., Oh‐Hohenhorst, Su Jung, Oing, Christoph, Eckhardt, Alicia, Burdak‐Rothkamm, Susanne, Alawi, Malik, Müller, Christian, Schüller, Ulrich, Maurer, Tobias, von Amsberg, Gunhild, Petersen, Cordula, Rothkamm, Kai, Mansour, Wael Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257417/ https://www.ncbi.nlm.nih.gov/pubmed/36694344 http://dx.doi.org/10.1002/1878-0261.13382 |
Ejemplares similares
-
Second-Generation Antiandrogen Therapy Radiosensitizes Prostate Cancer Regardless of Castration State through Inhibition of DNA Double Strand Break Repair
por: Elsesy, Mohamed E., et al.
Publicado: (2020) -
Loss of PTEN-assisted G2/M checkpoint impedes homologous recombination repair and enhances radio-curability and PARP inhibitor treatment response in prostate cancer
por: Mansour, W. Y., et al.
Publicado: (2018) -
Prevention of DNA Replication Stress by CHK1 Leads to Chemoresistance Despite a DNA Repair Defect in Homologous Recombination in Breast Cancer
por: Meyer, Felix, et al.
Publicado: (2020) -
Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin
por: Bauerschmidt, Christina, et al.
Publicado: (2010) -
Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer
por: von Amsberg, Gunhild, et al.
Publicado: (2022)